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Abstract: The aim of this study is to compare two accepted techniques; intravenous (IV) remifentanil infusion versus its combination
with paracervical block (PCB) in patients undergoing transvaginal ultrasound guided oocyte retrieval (TUGOR). One hundred
unpremedicated patients were divided into two groups to receive either IV remifentanil (Group R) or IV remifentanil plus PCB (Group
-1
-1
R+PCB). After monitoring cardiopulmonary parameters, remifentanil infusion of 0.25 µg kg min was started in both in groups.
Additionally, when the patient felt dizzy, PCB with 10 ml 1% lidocaine was performed only in Group R+PCB followed by remifentanil
-1
-1
infusion reduction to 0.15 µg kg min . Hemodynamic and respiratory parameters, adequacy of analgesia by Simple Numerical
Rating Scale (SNRS), total amount of remifentanil used, pregnancy rates and side effects were recorded. Hemodynamic changes
remained within clinical limits.There were clinically insignificant changes in peripheral oxygen saturation (SpO2) and end tidal carbon
dioxide (ETCO2) and they returned to baseline at the end of the procedure. SNRS higher than 3 at the time of 1st ovarian puncture
was observed in 6 and 0 patients, in Groups R and R+PCB, respectively (P < 0.05). The total amount of remifentanil used (µg) was
significantly higher in Group R (571.8 ± 167.4) than in Group R+PCB (357.2 ± 93.6). Pregnancy rates were 60% and 48% for
Groups R and R+PCB, respectively (p = 0.048). The incidence of nausea+vomiting was higher in Groups R (42%) than in Group
R+PCB (20%) (P < 0.05). Addition of PCB to IV remifentanil infusion was found to be superior in pain relief during 1st ovarian
puncture and reduced the incidence of nausea-vomiting with respect to IV remifentanil infusion alone.
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Introduction
Transvaginal ultrasound guided oocyte retrieval
(TUGOR) is a relatively invasive procedure generally
performed under light anesthesia with local
anaesthesics, opioids, hypnotics or benzodiazepines (1).
In recent years several opioids, such as, meperidine,
alfentanil, fentanyl and recently remifentanil, have been
used as a part of conscious sedation/monitored
anesthesia care (2, 3).
Remifentanil is a µ opioid agonist, which can be
administered by intravenous IV infusion. Short elimination
half life and increased metabolism by blood and tissue
esterases make remifentanil a suitable agent for outpatient
procedures such as IVF (4). After Brennan et al. (5)
showed that there were no toxic effects of remifentanil in

freeze and thawed mouse embryos, remifentanil has been
administered either as a sole agent or in combination with
propofol or midazolam in IVF (6-8).
Paracervical block (PCB) has been used in
combination with opioids, hypnotics, sedatives, and
acupuncture with or without premedication during
TUGOR (9-16). We have recently used the IV
remifentanil infusion and PCB combination and
presented our preliminary observational results (17).
However, addition of PCB to IV remifentanil infusion
has not yet been compared with IV remifentanil
infusion. Therefore, we aimed to compare two accepted
techniques; (IV) remifentanil infusion versus its
combination with (PCB) in patients undergoing
(TUGOR).
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Materials and Methods
One hundred unpremedicated patients, having
American Society of Anesthesiologists (ASA) class I or II
physical status and scheduled to undergo TUGOR, were
included in this prospective observational comparative
study. After we obtained approval from the local hospital
ethics committee, all patients were informed about the
procedure. Informed written consent was then obtained
from each patient.
Patients were selected to have an IVF attempt with
various etiologies (Table 1). Inclusion criteria consisted of
first IVF attempt, age under forty, and normal
responders. Induction of ovulation consisted of controlled
ovarian hyperstimulation with subcutaneous leuprolide
acetate 1 mg day-1 (Lucrin, Abboth, Turkey) for 14 days
-1
followed by a reduced dose of 0.5 mg day leuprolide
acetate throughout the cycle. Controlled ovarian
hyperstimulation was achieved with gonadotrophins,
either recombinant follicle stimulating hormone (Gonal FSerono, Puregon Organon, Turkey) or in combination
with human menopausal gonadotropin (Menogon, Erkim,
Turkey). The initial dose for each patient was adjusted
individually according to day 3 FSH levels, basal antral
follicle count and ovarian volume (150-450 IU day-1).
Cycle monitorization was done by serial measurement of
Table 1. Demographic characteristics and etiologies of infertility (Mean
± SD).
Group R
(n = 50)

Group R+PCB
(n = 50)

Age (years)

32.7 ± 5.9

33.5 ± 4.8

Height (cm)

159.7 ± 5.9

159.1 ± 5.5

Weight (kg)

61.8 ± 8.1

63.3 ± 13.4

10/50 (20%)

10/50 (20%)

1/50 (2%)

1/50 (2%)

Tuboperitoneal

6 (12%)

4 (8%)

Male-borderline

6 (12%)

3 (6%)

Male-severe

21 (42%)

18 (24%)

Anovulation

3 (6%)

6 (12%)

Unexplained

14 (28%)

12 (24%)

-

7 (14%)

50 (100%)

50 (100%)

Primary Infertility Rate
Living Child
Infertility Causes

Mixed
Type of treatment ICSI

ICSI: Intracytoplasmic sperm injection.
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serum E2 levels and ovarian folliculometry. Gonadotropin
dose was adjusted individually according to the follicular
growth. Ova collection was scheduled to be performed
within 36 hours of injection of human chorionic
gonadotropin (hCG) 10.000 IU (Profaci, Serono,
Turkey).
In order to assess the intensity of pain, 11-point
Simple Numerical Rating Scale (SNRS) was explained to
the patients before the procedure (0 corresponding to no
pain and 10 to the most severe pain). Patients were told
to indicate by the SNRS when they were asked to evaluate
the intensity of pain.
Heart rate (HR), non-invasive mean arterial pressure
(MAP) (Hewlett Packard M10258, Denmark), respiratory
rate (RR), peripheral oxygen saturation (SpO2) and end
tidal carbon dioxide (ETCO2) were measured continuously
(Odam Physiogard SM785, France) but recorded at
specific time points such as; before the induction, at the
st
nd
time of feeling dizzy, 1 and 2 ovarian punctures, at the
end of the procedure, 10, 20 and 30 min after the
procedure and on discharge. All patients received 3 l
-1
min oxygen through one of the nostrils while measuring
ETCO2 from the other nostril during spontaneous
ventilation. Physiologic saline (0.9% NaCl) 5 ml kg-1 h-1
was infused to the patients during the procedure.
The patients were allocated into two groups to receive
either IV remifentanil infusion (Group R, n=50) or IV
remifentanil infusion+PCB (Group R+PCB, n=50).
Patients were told to indicate when they started to feel
dizzy before the onset of remifentanil infusion. Both
groups received IV remifentanil (2 mg diluted in 20 ml
-1
-1
saline) infusion of 0.25 µg kg min via perfusor (IVAC
770, San Diego, U.S.A.) under the control of an
anesthesiologist. As soon as the patient told that she felt
-1
-1
dizzy, the remifentanil dose of 0.25 µg kg min was
continued in Group R and onset of retrieval procedure
was allowed to continue. In Group R+PCB, the same
remifentanil regimen followed by the PCB with 10 ml 1%
lidocaine injection was divided between 3 and 9 o’clock
positions of the cervix by the obstetricians (18). After
PCB, remifentanil infusion was decreased to 0.15 µg
-1
-1
kg min followed by the onset of retrieval procedure.
Remifentanil dose adjustment was performed according
to sedation and respiratory parameters.
Degree of sedation was evaluated according to a five
point scale (1: Patient sleeps and can not be awakened, 2:
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Patient sleeps and can be awakened with difficulty, 3:
Patient sleeps and can be easily awakened, 4: Patient is
co-operative, oriented, and tranquil 5: Patient is anxious
and agitated).
Sedation score and SNRS were measured every 5 min
but particularly recorded at the time of PCB, ovarian
st
nd
punctures of right and left sites (1 and 2 ovarian
punctures) and at the end of the procedure. Remifentanil
infusion was discontinued when the procedure was over.
When the sedation score was less than 3, RR less than
8 breath min-1, SpO2 less than 94% and ETCO2 higher
than 50 mmHg, remifentanil infusion was reduced by
0.05 µg kg-1 min-1 incrementally. Meanwhile when the
SNRS was higher than 3, remifentanil infusion was
-1
-1
increased by incremental doses of 0.05 µg kg min in 1
-1
-1
min intervals up to the dose of 0.25 µg kg min . The
total amount of remifentanil used and duration of the
procedure and side effects were recorded.
Patient satisfaction was assessed by asking about
overall satisfaction; whether they would prefer the same
anesthesia protocol should they need to undergo a similar
procedure in future.
Patients were allowed to pass to the transport table
without any support and they were transferred to the
recovery room. Patients free from side effects with stable
vital signs and able to walk without any help were
discharged after being observed for maximum 2 hours.
All retrieved ova were processed for intracytoplasmic
sperm injection. All embryos were cultured until day three
and the best quality embryos transferred. The mean
number of transferred embryo was 3.4 ± 0.8 and all
embryo transfers were performed under ultrasound
guidance. All patients received luteal support with vaginal
progesterone (Crinone, Serono, Turkey) for 14 days, or
-1
10th week of pregnancy. A β hCG above 10 mIU ml was
considered as pregnancy and a positive fetal heart beat
was considered as clinical pregnancy.
Statistical Analysis
The results of the present study were expressed as
mean ± standard deviation (Mean ± SD) or n (%) where
appropriate. Demographic variables, duration of
anesthesia and procedure, amount of remifentanil
consumption and number of collected oocytes were
compared by t-test. HR, MAP, SpO2, RR and, ETCO2 were
analyzed by repeated measures ANOVA followed by
Bonferroni correction. Chi square and Fischer’s exact

tests were used to assess differences in the incidence of
sedation score, side effects, causes of infertility, IVF rates
and patient numbers having SNRS higher than 3 between
the groups. P < 0.05 was considered as significant.

Results
Demographic variables of the groups were
comparable and infertility causes of the patients were
shown in Table 1.
The duration of procedure and anesthesia were
comparable in both groups (Table 2). Remifentanil
consumption was significantly lower in Group R+PCB
than in Group R (P < 0.05, Table 2). The number of
oocytes picked up were similar in both groups. Rates of
fertilization and retrieval were not significantly different
between the groups. Pregnancy rate per cycle (p =
0.048) and embryo transfer (p = 0.026) were
significantly higher in Group R than in Group R+PCB,
respectively. Fertilization was done by ICSI in all of the
retrieved ova (Table 2).
There were no significant differences in MAP and HR
both within and between the groups and they remained
within normal clinical limits throughout the procedure
(data not shown).
There were clinically insignificant fluctuations in SpO2
and ETCO2 values but they returned to clinically normal
limits at the end of the procedure (Figure 1). The number
of patients having RR < 8 breath min-1 were 12 and 8 in
groups R and R+PCB, respectively (P > 0.05).

Table 2. Characteristics of anesthesia and procedure in the groups
(Mean ± SD).

Duration of procedure (min)
Duration of anesthesia (min)
Remifentanil consumption (µg)
Number of oocytes picked up

Group R
(n = 50)

Group R+PCB
(n = 50)

35.9±10.9

30.2±8.3

45.4±12.2

39.0±9.0

571.8±167.4

357.2±93.6*

13.3 ± 7.1

11.8 ± 6.1

Retrieval rate (%)

86.3

91.4

Fertilization rate (%)

69.8

73.3

60

48*

62.5

51.1*

Pregnancy rate per cycle (%)
Pregnancy rate per embryo transfer (%)
*: P < 0.05 (between the groups)
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Discharge

Group R+PCB-SpO2
99.2
99
98.8
98.6
98.4
98.2
98
97.8

30 min
after the
procedure

20 min
after the
procedure

Group R-SpO2

10 min
after the
procedure

End of the
procedure

2nd
puncture

Group R+PCB-ETCO2

1st
puncture

Feeling
dizzy

Before
induction

End Tidal CO2 (mmHg)

Group R-ETCO2
45
40
35
30
25
20
15
10
5
0

SpO2 (%)
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Figure 1. The distribution of peripheral oxygen saturation (SpO2) and end tidal carbondioxide (ET CO2) concentration of
the groups recorded at specific time points. *:P < 0.05 (between the groups).

The number of patients having SNRS higher than 3 at
the time of 1st ovarian puncture in Group R was
significantly higher than in Group R+PCB (P < 0.05), but
there were no significant differences in the number of
patients having SNRS higher than 3 at other time points
between the groups (Table 3). Sedation scores of the
patients were 4 (co-operative and oriented) until the 1st
ovarian puncture in both groups. Although it remained
stable at 4 in Group R+PCB, it varied between 3 to 4 in
Group R.
The incidence of side effects; nausea, dysphagia,
shivering and headache were higher in Group R than in
Group R+PCB (P > 0.05). Only the incidence of
nausea+vomiting was significantly lower in Group R+PCB
than in Group R (P < 0.05, Table 4) and these patients
were treated with 10 mg IV metochlopromide. Although
the incidence of pruritus was less in Group R than in
Group R+PCB, it was not significantly different between
the groups (P > 0.05, Table 4) and it recovered
spontaneously without treatment. Muscle rigidity was not
observed in any of the groups (Table 4).

Table 3. Simple numeric rating scale (SNRS) of patients higher than 3
(n).
Group R
(n = 50)

Group R+PCB
(n = 50)

Paracervical block

0

0

1st ovarian puncture

6*

0

2nd ovarian puncture

3

3

End of procedure

0

1

*: P < 0.05 between the groups
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Table 4. Incidence of side effects [n (%)].
Group R
(n=50)

Group R+PCB
(n=50)

Nausea

26 (52)

18 (36)

Nausea + vomiting

21 (42)

10 (20)*

Dysphagia

6 (12)

2 (4)

Pruritus

18 (36)

20 (40)

Headache

4 (8)

3 (6)

Shivering

10 (20)

7 (14)

Nystagmus

2 (4)

2 (4)

Muscle rigidity

0 (0)

0 (0)

*: P<0.05 between the groups

Patient satisfaction rate did not differ significantly
between the groups; 47 out of 50 (94%) versus 48 out
of 50 (96%) in Groups R and R+PCB, respectively. Since
patients were highly satisfied with the anesthesia
technique, they stated that they would prefer the same
anesthesia protocol should they need to undergo a similar
procedure in future.

Discussion
In the present study either remifentanil infusion alone
or remifentanil infusion plus PCB produced high patient
satisfaction rate and similar side effects except
nausea+vomiting. No clinically significant changes were
observed in blood pressure, heart rate, peripheral oxygen
saturation, and end tidal carbondioxide pressure. The
combination of PCB with remifentanil resulted in lower
remifentanil consumption leading to less nausea +
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vomiting and more pain relief during the 1st ovarian
puncture of TUGOR.
Remifentanil and lidocaine were traced in follicular
fluid (7, 9, 20). No adverse effects of these drugs on
pregnancy rates have been reported (21). Hammadeh et
al (22) combined remifentanil with hypnotics and
benzodiazepines and reported no adverse effects on
fertilization, cleavage and pregnancy rates, with better
rates than general anesthesia. Therefore, we used both
drugs in our anesthesia protocols.
The lidocaine dose used for PCB may vary (11). It has
been reported that the efficiency of different lidocaine
doses on fertilization, cleavage and pregnancy rates were
similar in TUGOR (15,16). A higher pregnancy rate has
been achieved with electroacupuncture and PCB with
respect to alfentanil use (9) . When Gonen et al (10)
compared local anesthesia plus sedation, epidural
anesthesia and general anesthesia including nitrous oxide,
they reported that the pregnancy rates were similar.
Jensen et al (23) compared intravenous sedation and
general anesthesia and found that the longer the general
anesthesia duration the lower the fertilization rate, but
not with local anesthesia. In contrast to the study
recommending that 10 ml of 0.5% (50 mg) lidocaine was
the lowest effective dose in PCB in TUGOR (11), in the
present study we divided 1% 10 ml (100 mg) lidocaine
between two injection sites in our unpremedicated
patients. In the study of Ng et al (11), the reason for
finding 50 mg lidocaine in PCB to be effective should be
the heavy premedication (im 50 mg of pethidine and 25
mg of prometazine followed by IV 5 mg of diazepam and
25 mg of pethidine) administered prior to intravenous
sedatives and/or analgesics. The local anesthetic agents
were supposed to pass promptly to the intravascular
space due to increased structures at the apex of the
vagina causing high blood peak levels. However, the
lidocaine (100 mg) dose we used is within recommended
doses in clinical practice (50-200 mg) (16, 19).
We have recently reported that IV remifentanil
infusion and PCB combination was effective in relieving
pain during TUGOR (17). In that preliminary
observational study, 104 patients received the same
protocol as Group R+PCB of the present study.
However, this combination was not compared with IV
remifentanil infusion alone in regard to side effects.
Concerning both groups of the present study,
significantly less nausea+vomiting was observed in

Group R+PCB (20%) than in Group R (42%). The total
amount of remifentanil used was significantly lower in
the Group R+PCB (357.2 ± 93.6 µg) than in Group R
(571.8 ± 167.4 µg.). When remifentanil infusion+PCB
groups of both studies were taken into account, the
incidences of nausea+vomiting were comparable
(34.6% versus 20%) and the corresponding amounts of
remifentanil used were comparable also (407.5±123.2
µg vs 357.2±93.6 µg for our previous and the present
studies, respectively) as well. The side effects, such as
pruritus which was observed in 36% and 40% of
patients in Groups R and R+PCB respectively in this
study, were less frequent (54%) with respect to
Wilhelm et al (6) who used remifentanil as a single agent
for oocyte retrieval.
The contribution of PCB in this technique not only
reduced side effects but also provided excellent analgesia
especially during the 1st ovarian puncture, which was
one of the most painful stages of the TUGOR
procedure.
The hemodynamic and respiratory side effects of
remifentanil are dose dependent (4). We observed
clinically insignificant changes in MAP, HR, SpO2 and
ETCO2 levels with respect to baseline values according to
our preliminary results (17). In the present study MAP
and HR did not differ within and between the groups and
SpO2 and ETCO2 levels showed fluctuations due to dose
adjustment of remifentanil but those fluctuations were
within clinically acceptable limits.
Wilhelm et al (6) administered remifentanil alone and
stated that the remifentanil infusion doses higher than
0.25 µg kg-1 min-1 may cause respiratory depression. In
our study, after the onset of retrieval procedure, initial
remifentanil dose was reduced to maintain conscious
sedation, but when patients’ SNRS became 3, incremental
increase was carried out to provide adequate analgesia.
Therefore, we did not need to use remifentanil doses
higher than the initial dose (0.25 µg kg-1 min-1). We
found that mean SpO2 and ETCO2 levels did not exceed
normal clinical limits at any time point. However, the
limitation of measuring ETCO2 by a nasal canula gives
only a rough estimation of PaCO2 which is not always
reliable in diagnosing respiratory depression. The number
of patients having RR < 8 breath min-1 were 12 and 8 in
groups R and R+PCB, respectively. Patients were told to
take a deep breath since they were cooperative and able
to obey verbal commands in this situation.
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Casati et al (8) reported moderate muscle rigidity in
patients receiving midazolam and remifentanil together.
Arnt et al (24) reported mild thorax rigidity in patients
premedicated with midazolam receiving IV remifentanil.
Although Wilhelm et al (6) observed respiratory difficulty
in 10% of the patients, they reported no muscle rigidity.
We also have not observed any muscle rigidity either in
the present study in both groups or in our previous study
(17) because we did not use benzodiazepins or hypnotics
in premedication. The explanation for this finding could
be the lack of premedication in both studies.

factors related to patients and surgeons might have a role
in fertility.
In conclusion, addition of PCB to remifentanil infusion
reduced remifentanil requirement and side effects due to
remifentanil use during TUGOR. The two anesthesic
techniques, remifentanil plus PCB being superior,
provided sufficient analgesia and patient comfort under
monitored anesthesia care.

Corresponding author:
Berrin GÜNAYDIN
Department of Anesthesiology and Reanimation,
Faculty of Medicine,
Gazi University,
06500 Beflevler, Ankara - TURKEY
E-mail : gunaydin@gazi.edu.tr

The number of follicules aspirated and number of
oocytes retrieved and the rate of fertilization and
cleavage in both groups, pregnancy rate per cycle and
embryo transfer decreased significantly in Group R+PCB
with respect to Group R. We think that this reduction is
independent of our anesthesia technique because many

References
1.

Boyers SP, Lavy G, Russell JB et al. A paired analysis of in vitro
fertilization and cleavage rates of first- versus last- recovered
preovulatory human oocytes exposed to varying interval of 100%
CO2 pneumoperitoneum and general anesthesia. Fertil Steril 48:
969-74, 1987.

10.

Gonen O, Schulman A, Ghetler Y, et al. The impact of different
types of anesthesia on in vitro fertilization embryo transfer
treatment outcome. J Assist Reprod Genet 12: 678-82, 1995.

11.

Ng EHY, Miao B, Ho PC. A randomized double-blind study to
compare the effectivenes of three different doses of lignocaine
used in paracervical block during oocyte retrieval. J Assist Reprod
Genet 20: 8-12, 2003.

12.

Ben –Shlomo I, Amodia I, Levran D, et al. Midazolam-fentanyl
sedation in conjuction with local anesthesia during oocyte retrieval
for in vitro fertilization. J Assist Reprod Genet 9: 83-5, 1992.

2.

Ditkoff EC, Plump J, Selick A et al. Anesthesia practices in the
United States common to in vitro fertilization (IVF) centers. J
Assist Reprod Genet 11: 115-7, 1997.

3.

Trout SW, Vallerand AH, Kemmann E. Conscious sedation for in
vitro fertilization. Fertil Steril 69: 799-808, 1998.

4.

Glass PSA, Gan TJ, Howell S. A review of the pharmacokinetics
and pharmacodynamics of remifentanil. Anesth Analg 89: S7-14,
1999.

13.

Godoy H, Erard P, De Munck L et al. Comparison of two local
anesthescs in transvaginal ultrasound-guided oocyte retrieval.
Hum Reprod 7: 1093, 1993.

5.

Brennan G, Yarmush, Stein D, et al. The effect of remifentanil on
the percentage of frozen-thawed mouse embryos that proceed to
the blastocyte stage. J Soc Gynecol Invest 4: 173, 1997.

14.

6.

Wilhelm W, Biedler A, Hammadeh ME et al. Remifenatnil for
oocyte retrieval : A new single-agent monitored anaesthesia care
technique. Anaesthesist 48: 698-704, 1999.

Gohar J, Lunenfed E, Potashnik G, et al. The use of sedation only
during oocyte retrieval for in vitro fertilization patients pain selfassesments versus doctors evaluations. J Assist Reprod Genet 10:
476-8, 1993.

15.

Ng EHY, Tang OS, Chui DKC et al. A prospective, randomized,
double-blind and placebo-controlled study to assess the efficacy of
paracervical block in the pain relief during egg collection in IVF.
Hum Reprod 14: 2783-7, 1999.

16.

Ng EHY, Tang OS, Chui DKC, et al Comparison of two different
doses of lignocaine used in paracervical block during oocyte
collecting in an IVF programme. Hum Reprod 15: 2148-51,
2000.

17.

Kaya K, Öztürk E, Tuncer B et al. Remifentanil infusion and
paracervical block combination for transvaginal ultrasound guided
oocyte retrieval. Turk J Med Sci 35: 99-105, 2005.

7.

Achwal M, Abuzeid M, Bowenschen JL, et al. Remifentanil and
fentanyl concentrations in follicular fluid during transvaginal
oocyte retrieval. Anesthesiology 90 ( Suppl): A16, 1999.

8.

Casati A, Valentini G, Zangrillo A, et al. Anesthesia for ultrasound
guided oocyte retrieval. Midazolam/remifentanil versus
propofol/fentanyl regimens. Eur J Anaesthesiol 16: 7738, 1999.

9.

Stener-Victorin E, Naldenström U, Nilsson L et al. A prospective
randomized study of electro-acupuncture versus alfentanil as
anesthesia during oocyte aspiration in in-vitro fertilization. Hum
Reprod 14: 2480-4, 1999.

110

E. ÖZTÜRK, B. GÜNAYDIN, O. KARABACAK, B. TUNCER, M. ERDEM, A. ERDEM, B. TIRAfi, K. KAYA

18.

Stubblefield PG. Control of pain in women undergoing abortion.
Int J Gynaecol Obstet 3: 131-40, 1989.

19.

Wikland M, Evers H, Jakobsson AH. The concentration of
lidocaine in follicular fluid when used for paracervical block in a
human IVF-ET programme. Hum Reprod 5: 920-3, 1990.

20.

Bailey-Pridham DD, Reshef E, Drury CL, et al. Follicular fluid
lidocaine levels during transvaginal oocyte retrieval. Fertil Steril
53: 171-3, 1990.

21.

Wilhelm W, Hammadeh ME, White PF et al. General anesthesia
versus monitored anesthesia care with remifentanil for assisted
reproductive technologies: Effect on pregnancy rate. J Clin Anesth
14: 1-145, 2002.

22.

Hammadeh ME, Wilhelm W, Huppert A et al. Effects of general
anesthesia vs. sedation on fertilization, cleavage and pregnancy
rates in an IVF program. Arch Gynecol Obstet 263: 56-9, 1999.

23.

Jensen JT, Boyers SP, Grunfeld LH et al. Anesthesia exposure may
affect fertilization rate of human oocytes collected by ultrasound
aspiration. 5th World Congress on In Vitro Fertilization and
Embryo-transfer 1987, Norfolk, Virginia, April 5-10,
Birmingham, The American Fertility Society, 1987; p48.

24.

Arnt Von M, Kreienmeyer J, Vagts DA et al. RemifentanilAnalgezien zur Follikel-punksion für In-Vitro-Fertilization.
Anaesthesiol Reanimat 29: 69-73, 2004.

111

